Serum Amyloid A Protein-Rich High-Density Lipoprotein, Human Serum

Native, high-density lipoprotein (HDL) enriched in serum amyloid A from human serum. Serum amyloid A (SAA) is an acute phase reactant that can become the predominant apolipoprotein in HDL during severe inflammatory conditions. Sold on the basis of total protein content. ≥ 80 µg/ml SAA content by EIA.

Native, high-density lipoprotein (HDL) enriched in serum amyloid A from human serum. Serum amyloid A (SAA) is an acute phase reactant that can become the predominant apolipoprotein in HDL during severe inflammatory conditions. Sold on the basis of total protein content. ≥80 µg/ml SAA content by EIA.

Please refer to vial label for lot-specific concentration.

In 150 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl, 0.1% NaN₃, pH 8.0.

Following initial thaw, aliquot and freeze (-20°C).







From Catalog:

Alt. Names- removed SAA

Desc. Field- added "High-density lipoprotein (HDL) enriched in serum amyloid A. Serum amyloid A (SAA) is an acute phase reactant that can become the predominant apolipoprotein in HDL during severe inflammatory conditions."

Prepared from serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Toxicity: Standard Handling (A)